Stock IME IMAGIN MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Imagin Medical Inc.

Equities

IME

CA45250L2049

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 02:29:20 2024-02-02 pm EST 		5-day change 1st Jan Change
0.015 CAD -.--% Intraday chart for Imagin Medical Inc. -.--% -70.00%
2023 Imagin Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
2023 Imagin Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI

Valuation

Fiscal Period: September 2017 2018 2019 2020 2021 2022
Capitalization 1 6.759 23.96 6.953 4.459 4.335 3.141
Enterprise Value (EV) 1 6.613 18.14 4.68 4.431 15.79 16.22
P/E ratio -4.3 x -2.5 x -1.56 x -0.95 x -0.37 x -1.16 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -4.53 x -2.32 x -1.11 x -1.18 x -4.67 x -4.77 x
EV / FCF -128 x -11.4 x -2.07 x -2.07 x -6.83 x -10.2 x
FCF Yield -0.78% -8.81% -48.3% -48.3% -14.7% -9.76%
Price to Book -13.3 x 4.13 x 3.29 x -13.5 x -0.38 x -0.24 x
Nbr of stocks (in thousands) 2,503 6,474 6,953 8,917 9,127 10,830
Reference price 2 2.700 3.700 1.000 0.5000 0.4750 0.2900
Announcement Date 1/18/18 12/19/18 12/24/19 12/22/20 12/24/21 12/22/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -1.46 -7.834 -4.21 -3.762 -3.38 -3.402
EBIT 1 -1.475 -7.848 -4.235 -3.794 -3.41 -3.449
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -1.542 -7.958 -4.457 -4.377 -11.47 -2.492
Net income 1 -1.542 -7.958 -4.457 -4.377 -11.47 -2.492
Net margin - - - - - -
EPS 2 -0.6283 -1.482 -0.6416 -0.5275 -1.268 -0.2493
Free Cash Flow 1 -0.0517 -1.597 -2.26 -2.14 -2.314 -1.584
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/18/18 12/19/18 12/24/19 12/22/20 12/24/21 12/22/22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - 11.5 13.1
Net Cash position 1 0.15 5.82 2.27 0.03 - -
Leverage (Debt/EBITDA) - - - - -3.389 x -3.846 x
Free Cash Flow 1 -0.05 -1.6 -2.26 -2.14 -2.31 -1.58
ROE (net income / shareholders' equity) 800% -290% -110% -491% 193% 20%
ROA (Net income/ Total Assets) -249% -150% -61.1% -175% -429% -203%
Assets 1 0.6197 5.323 7.298 2.505 2.676 1.229
Book Value Per Share 2 -0.2000 0.9000 0.3000 -0.0400 -1.250 -1.230
Cash Flow per Share 2 0.1000 0.8700 0.3300 0 0.0300 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 1/18/18 12/19/18 12/24/19 12/22/20 12/24/21 12/22/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Medical Devices

1st Jan change Capi.
IMAGIN MEDICAL INC. Stock Imagin Medical Inc.
-70.00% 119K
NIBEC CO., LTD. Stock NIBEC Co., Ltd.
-20.60% 128M
COLLPLANT BIOTECHNOLOGIES LTD. Stock CollPlant Biotechnologies Ltd.
-7.82% 67.46M
NOVACYT Stock Novacyt
+14.87% 61.68M
KIM FOREST ENTERPRISE CO., LTD. Stock Kim Forest Enterprise Co., Ltd.
+6.64% 60.58M
BONUS BIOGROUP LTD. Stock Bonus BioGroup Ltd.
+0.60% 51.45M
Bio Medical Devices
  1. Stock Market
  2. Equities
  3. IME Stock
  4. Financials Imagin Medical Inc.